Bionano Genomics, Inc. (BNGO) earnings
BNGO earnings moved a median of -2.27% by the close. Quarterly and annual BNGO reports and results, each read against the price at its own news timestamp. Back to the BNGO overview →
26 measured BNGO earnings events.
Where these BNGO earnings landedvs 26 measured BNGO earnings reactions
| Middle 50% of BNGO earnings reactions | -7.01% to -0.19% |
|---|---|
| Median reaction (to close) | -2.27% |
| Measured reactions | 26 |
Point-in-time · zero look-ahead
Half of the 26 BNGO earnings events with a measured close landed between -7.01% and -0.19%; 23% closed up.
| Date | Headline | Event | 5-min | To close |
|---|---|---|---|---|
| Bionano to Report Second Quarter 2026 Financial Results and Host a Conference Call Webcast on August 10, 2026 | Press release | +0.00% | +0.00% | |
| Bionano Reports First Quarter 2026 Results and Provides a Business Update | Press release | -0.78% | -7.03% | |
| Form 10-Q Bionano Genomics, Inc. For: Mar 31 | SEC filing · Form 10-Q | -0.78% | -7.03% | |
| Bionano to Report First Quarter 2026 Financial Results and Host a Conference Call Webcast on May 13, 2026 | Press release | +0.85% | -0.85% | |
| Form 10-K Bionano Genomics, Inc. For: Dec 31 | SEC filing · Form 10-K | -0.15% | -9.23% | |
| Bionano to Report Third Quarter 2025 Financial Results and Host a Conference Call Webcast on November 13, 2025 | Press release | -1.62% | -2.70% | |
| Bionano Reports Second Quarter 2025 Results and Highlights Recent Business Progress | Press release | +2.23% | -3.80% | |
| Form 10-Q Bionano Genomics, Inc. For: Jun 30 | SEC filing · Form 10-Q | +2.23% | -3.80% | |
| Bionano to Report Second Quarter 2025 Financial Results and Host a Conference Call Webcast on August 14, 2025 | Press release | -0.32% | -1.67% | |
| Bionano Reports First Quarter 2025 Results and Highlights Recent Business Progress | Press release | +2.79% | -8.61% | |
| Form 10-Q Bionano Genomics, Inc. For: Mar 31 | SEC filing · Form 10-Q | +2.79% | -8.61% | |
| Bionano to Report First Quarter 2025 Financial Results and Host a Conference Call Webcast on May 14, 2025 | Press release | +0.53% | +2.67% | |
| Form 10-K Bionano Genomics, Inc. For: Dec 31 | SEC filing · Form 10-K | +1.05% | +8.77% | |
| Form 10-Q Bionano Genomics, Inc. For: Sep 30 | SEC filing · Form 10-Q | -0.20% | -1.91% | |
| Bionano Reports Third Quarter 2024 Results and Highlights Recent Business Progress | Press release | -2.67% | -2.33% | |
| Bionano to Report Third Quarter 2024 Financial Results and Host a Conference Call and Webcast on November 13, 2024 | Press release | -2.63% | -6.97% | |
| Bionano Reports Second Quarter 2024 Results and Highlights Recent Business Progress | Press release | +1.06% | -10.53% | |
| Form 10-Q Bionano Genomics, Inc. For: Jun 30 | SEC filing · Form 10-Q | +1.06% | -10.53% | |
| Bionano to Report Second Quarter 2024 Financial Results and Host a Conference Call and Webcast on August 7, 2024 | Press release | -2.18% | -0.74% | |
| Bionano Reports First Quarter 2024 Results and Highlights Recent Business Progress | Press release | +1.80% | +3.42% | |
| Form 10-Q Bionano Genomics, Inc. For: Mar 31 | SEC filing · Form 10-Q | +1.80% | +3.42% | |
| Bionano to Report First Quarter 2024 Financial Results and Host a Conference Call and Webcast on May 8, 2024 | Press release | +0.16% | +7.26% | |
| Form 10-K Bionano Genomics, Inc. For: Dec 31 | SEC filing · Form 10-K | -5.08% | +2.54% | |
| Bionano Reports Third Quarter 2023 Results and Highlights Recent Business Progress | Press release | -2.23% | -2.21% | |
| Form 10-Q Bionano Genomics, Inc. For: Sep 30 | SEC filing · Form 10-Q | -2.23% | -2.21% | |
| Bionano to Report Third Quarter 2023 Financial Results and Host a Conference Call and Webcast on November 8, 2023 | Press release | -10.91% | -6.34% |
Keep exploring
More BNGO: analyst actions → · SEC filings → · BNGO overview →
Other Healthcare names and their earnings
| Ticker | Events | Median 30-min | % positive |
|---|---|---|---|
| Theravance Biopharma, Inc. - Ordinary Shares (TBPH) | 326 | +0.10% | 57% |
| Verona Pharma plc - American Depositary Shares (VRNA) | 325 | -0.03% | 39% |
| Wave Life Sciences, Inc. (WVE) | 321 | -0.14% | 45% |
| Pulse Biosciences, Inc (PLSE) | 320 | +0.18% | 55% |
Same sector, same measurement: percent move vs. the price at the news timestamp, read at 30 minutes. Sample sizes differ, so the medians are comparable but the confidence behind them is not. These are each name’s all-news baseline, not its earnings — that is what the link opens.